The Scientific Council of WHO experts has published its first report on accelerating access to genomics for global health. The report says there is no ethical or scientific justification for countries with fewer resources to gain access to such technologies
long after rich countries.
The field of genomics uses methods in biochemistry, genetics, and molecular biology to understand and use biological information in DNA and RNA, with benefits for medicine and public health – especially during the COVID-19 pandemic – as
as well as agriculture, biological and other research. The report calls for broadening access to genomics technologies, especially in low and middle income countries (LMICs), by addressing gaps in funding, laboratory infrastructure, materials,
and highly trained staff.
While the costs of creating and extending genomics technologies are falling – making them increasingly feasible for all countries – they can and should be further reduced. A range of tools to make genomics technologies more affordable
for LMICs have been developed, including tiered pricing; providing intellectual property rights to low-cost versions; and cross-subsidization where profits from one area are used to finance another.
“Genomic technologies are driving some of the most groundbreaking research currently taking place. However, the benefits of these tools will not be fully realized if they are not implemented worldwide. Only through fairness can science achieve its full potential impact
and improve health for everyone, everywhere, ‘said Dr. Soumya Swaminathan, WHO Principal Scientist. “By summoning and coordinating the world’s leading minds, as we do through our Science Council, WHO acts as a global engine of analysis
What is the simple definition of genomics?
to meet the world’s most pressing health challenges ”.
The Scientific Council, made up of 9 leading scientists and public health experts from around the world, was established in April 2021 by WHO’s Director General, Dr. Read also : Jury Rules Physician Health Care Fraud Scheme. Tedros Adhanom Ghebreyesus to advise him on high priority and progress issues
What is genomics the study of?
technology that can directly improve global health. The Scientific Council has identified genomics as the main focus of its first study, given the significant public health implications; has many effective applications in the fight against infectious diseases, cancer,
What is the simple definition of genome?
and other chronic diseases; and new opportunities to implement expensive technologies, even in LMICs. Read also : Wire WIC for better working families with no food.
What is genomics give types of genomics?
“It’s already clear that genomics can make a huge contribution to human health, from testing populations for infectious agents such as the virus that causes COVID-19, to predicting and treating a wide variety of diseases such as cancer and developmental diseases. On the same subject : Intellect partners with MSIG Hong Kong to provide holistic mental health support to its policyholders.
disturbance. Maintaining fairness in the implementation of these technologies is critical to achieving the enormous potential benefits to human health, “said Council President Professor Harold Varmus, Nobel Laureate and former director of the USA National
What are the different types of genomes?
Health Institutes.
What is genomics give application genomics?
To promote the adoption or wider use of genomics, the report’s recommendations cover four themes: advocacy, implementation, collaboration, and related ethical, legal and social issues:
What is difference between genetics and genomics?
To follow up the recommendations and monitor their application in all four main areas, the report also recommends the creation by WHO of a Genomics Committee. A key responsibility proposed to the Genomics Committee is to convene commercial organizations
develop and implement ways to make their products and technologies affordable in LMICs.
Is genetics Part of genomics?
The report is the result of the publication of the WHO’s 10-year genomic surveillance strategy for pathogens. Genomic surveillance has played a key role in the global response to COVID-19, and countries such as South Africa have been able to make a significant contribution to
